Due to the interactions among PPAR-γ, Nrf2, and NF-κB, it has been proposed that coactivation of Nrf2 and PPAR-γ may improve the therapeutic outcome of neurological disorders [31]. This evidence concerns the gene NFKB1 and nervous system disorder.